Results 21 to 30 of about 50 (48)

Dialysis Complications in AKI Patients Treated with Extended Daily Dialysis: Is the Duration of Therapy Important? [PDF]

BioMed Research International, 2014
This trial aimed to compare the dialysis complications occurring during different durations of extended daily dialysis (EDD) sessions in critically ill AKI patients. We included patients older than 18 years with AKI associated with sepsis admitted to the intensive care unit and using noradrenaline dose ranging from 0.3 to 0.7 μg/kg/min.
Bianca Ballarin Albino, André Luis Balbi, Daniela Ponce   +2 more
openaire   +4 more sources

Confluent and reticulated papillomatosis treated with extended-release minocycline

Indian Dermatology Online Journal, 2023
Fathima Shafi, M Manjunath Shenoy, Deepa M Thomas, Malcolm Pinto   +3 more
openaire   +3 more sources

TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES

Retina, 2015
A review of treat-and-extend regimens (TERs) with intravitreal anti-vascular endothelial growth factor agents in retinal diseases.There is a lack of consensus on the definition and optimal application of TER in clinical practice. This article describes the supporting evidence and subsequent development of a generic algorithm for TER dosing with anti ...
Freund, K Bailey, Korobelnik, Jean-François, Devenyi, Robert, Framme, Carsten, Galic, John, Herbert, Edward, Hoerauf, Hans, Lanzetta, Paolo, Michels, Stephan, Mitchell, Paul, Monés, Jordi, Regillo, Carl, Tadayoni, Ramin, Talks, James, Wolf, Sebastian   +14 more
openaire   +4 more sources

Aflibercept for central retinal vein occlusions: long-term outcomes of a ‘Treat-and-Extend’ regimen

BMJ Open Ophthalmology
Background/aimsThis study reports on the long-term functional and anatomical outcomes of patients with central retinal vein occlusion (CRVO) treated under the Bern treat-and-extend (T&E) protocol.MethodsObservational study. Treatment-naive patients with CRVO and consecutive macular oedema treated with aflibercept were included. The T&E protocol
Damian Jaggi, Thanoosha Nagamany, Sebastian Wolf, Martin S. Zinkernagel, Florian M. Heussen   +4 more
openaire   +3 more sources

Faricimab Treat-and-Extend for Diabetic Macular Edema

Purpose: To evaluate the 2-year efficacy, durability, and safety of dual angiopoietin-2 and vascular endothelial growth factor (VEGF) A pathway inhibition with intravitreal faricimab according to a personalized treat-andextend (T&E)-based regimen with up to every-16-week dosing in the YOSEMITE and RHINE (ClinicalTrials.govidentifiers, NCT03622580 and ...
WONG, T, YOSEMITE AND RHINE INVESTIGATORS, YOSEMITE and RHINE Investigators   +2 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT FOR RETINAL ANGIOMATOUS PROLIFERATION

Retina, 2016
To evaluate the effects of aflibercept therapy using a treat-and-extend regimen on treatment-naïve retinal angiomatous proliferation (RAP) and development of retinal pigment epithelium (RPE) atrophy.We retrospectively studied 17 treated eyes with RAP and 13 untreated fellow eyes.
Shoji Kishi, Taku Sato, Takashi Hiroe, Kensuke Mimura, Masahiro Morimoto, Ryo Mukai, Kensuke Ehara, Hidetaka Matsumoto, Maki Takahashi, Mayuko Takayama   +9 more
openaire   +3 more sources

Giant ancient schwannoma of pancreatic head treated by extended pancreatoduodenectomy

Pancreatology, 2004
We report a case of a 55-year-old woman who was transferred from another center to our university clinic after diagnostic laparotomy with a pancreatic head tumor which was seen to encase the portal vein. Although intraoperative biopsies were performed, a histologic diagnosis of the tumor was not possible before giving suspect to a malignant tumor being
Dobschütz, Ernst von, Walch, Axel Karl, Werner, Martin, Hopt, Ulrich T., Adam, Ulrich   +4 more
openaire   +4 more sources

The Cost-Effectiveness of Ranibizumab Treat and Extend Regimen Versus Aflibercept in the UK

Advances in Therapy, 2016
Wet age-related macular degeneration (AMD) is a chronic eye condition that causes severe deterioration of vision and even blindness. Current wet AMD treatment in the UK involves the vascular endothelial growth factor inhibitors ranibizumab and aflibercept.
Lindsay Claxton, Kelly Fleetwood, Rose Wickstead, Ruth Pulikottil-Jacob, Jeanette Kusel, Matthew Taylor, W Ghosh   +6 more
openaire   +3 more sources

Long-term outcome of treat and extend intravitreal ziv-aflibercept therapy

British Journal of Ophthalmology, 2018
AimTo assess the 30-month outcome of treat and extend (TAE) intravitreal ziv-aflibercept therapy in eyes with macular diseases.MethodsIn this prospective study, consecutive subjects received intravitreal 0.05 mL ziv-aflibercept (1.25 mg) injections for various macular diseases. Outcome measures were best-corrected visual acuity (BCVA) (logarithm of the
Ahmad M. Mansour, Abdulrazzak Charbaji, Abdulrazzak Charbaji, Jay Chhablani, Michel Eid Farah, Hana A Mansour   +5 more
openaire   +3 more sources

Hydrosalpinx treated with extended doxycycline does not compromise the success of in vitro fertilization

Fertility and Sterility, 2001
To determine if extended treatment with doxycycline before and after an in vitro fertilization (IVF) procedure can minimize the detrimental effect of a hydrosalpinx.Retrospective analysis.University IVF program.Patients undergoing IVF, including 17 with a hydrosalpinx, 25 with adhesions or proximal tubal occlusion, and 22 with endometriosis or ...
William D. Schlaff, Kathleen E. Tucker, Caleb A. Awoniyi, Bradley S. Hurst, Bradley S. Hurst   +4 more
openaire   +3 more sources